Analysis of PorA variable region 3 in meningococci:: implications for vaccine policy?

被引:26
作者
Clarke, SC
Diggle, MA
Mölling, P
Unemo, M
Olcén, P
机构
[1] Stobhill Gen Hosp, N Glasgow Univ Hosp NHS Trust, Scottish Meningococcus & Pneumococcus Ref Lab, Glasgow G21 3UW, Lanark, Scotland
[2] Univ Glasgow, Fac Biomed & Life Sci, Glasgow, Lanark, Scotland
[3] Orebro Univ Hosp, Natl Ref Lab Pathogen Neisseria, Orebro, Sweden
关键词
Neisseria meningitidis; meningococci; PorA; sequence typing; vaccine;
D O I
10.1016/S0264-410X(03)00033-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Outer membrane protein (OMP) vaccines are being developed against Neisseria meningitidis serogroup B which may provide protection against common circulating serotypes and serosubtypes in some countries. However, limited data is available in Europe from genosubtyping meningococci. We therefore undertook a retrospective analysis of the three main variable regions, VR1, VR2 as well as VR3, of the porA gene from N. meningitidis isolated from different countries, mainly from Scotland and Sweden. Analysis of this gene showed that, amongst 226 strains studied, there were a total of 78 different strains. No new VR1 or VR2 alleles were found but five new VR3 alleles are described. Our data indicates the importance of analysing the VR3 region of PorA in addition to VR I and VR2 and also highlights, in general terms, the need for genosubtyping meningococci. Such analyses have major implications for the design of new meningococcal vaccines. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2468 / 2473
页数:6
相关论文
共 36 条
[1]   Neisseria meningitidis: Vaccines and vaccine candidates [J].
AlaAldeen, DAA ;
Cartwright, KAV .
JOURNAL OF INFECTION, 1996, 33 (03) :153-157
[2]   Sequencing of porA from clinical isolates of Neisseria meningitidis defines a subtyping scheme and its genetic regulation [J].
Arhin, FF ;
Moreau, F ;
Coulton, JW ;
Mills, EL .
CANADIAN JOURNAL OF MICROBIOLOGY, 1998, 44 (01) :56-63
[3]   Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins [J].
Cartwright, K ;
Morris, R ;
Rümke, H ;
Fox, A ;
Borrow, R ;
Begg, N ;
Richmond, P ;
Poolman, J .
VACCINE, 1999, 17 (20-21) :2612-2619
[4]   Semiautomation of multilocus sequence typing for the characterization of clinical isolates of Neisseria meningitidis [J].
Clarke, SC ;
Diggle, MA ;
Edwards, GFS .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (09) :3066-3071
[5]   Introduction of an automated service for the laboratory confirmation of meningococcal disease in Scotland [J].
Clarke, SC ;
Diggle, MA ;
Reid, JA ;
Thom, L ;
Edwards, GFS .
JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (07) :556-557
[6]   Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6 [J].
Connolly, M ;
Noah, N .
EPIDEMIOLOGY AND INFECTION, 1999, 122 (01) :41-49
[7]   Immunogenicity and safety of monovalent P1.7h,4 meningococcal outer membrane vesicle vaccine in toddlers:: comparison of two vaccination schedules and two vaccine formulations [J].
de Kleijn, ED ;
de Groot, R ;
Lafeber, AB ;
Labadie, J ;
van Limpt, KCJP ;
Visser, J ;
Berbers, GAM ;
van Alphen, L ;
Rümke, HC .
VACCINE, 2000, 19 (9-10) :1141-1148
[8]  
ELDRIDGE J, 1978, MED LAB SCI, V35, P63
[9]   Multilocus sequence typing [J].
Enright, MC ;
Spratt, BG .
TRENDS IN MICROBIOLOGY, 1999, 7 (12) :482-487
[10]  
FINNE J, 1987, J IMMUNOL, V138, P4402